♟️ Tuesday 27 October 2026 Tue, 27 Oct 2026

NRW Holdings delivered record FY26 revenue and earnings after folding Fredon into a new EMIT division, while debt-funded expansion lifted leverage. The company enters FY27 with A$7.5 billion of secured work, a larger banking facility and a sharper test of whether diversification can keep converting into cash.

Euroz Hartleys Group delivered a sharp FY26 earnings recovery as revenue rose 43.6% and net profit increased 62.4%, while its $145 million sale of Capital Markets to BMO moved towards completion. The transaction will leave the ASX-listed group focused on Private Wealth, with a strategic question hanging over how much earnings power survives the separation.

KGL Resources has moved its Jervois copper project from funding and planning into full execution, with an A$300 million equity raising completed and A$275.4 million in cash at quarter-end. First concentrate remains targeted for the first half of 2028, but the next test is construction delivery rather than project approval.

Hydrix reported stronger contract momentum and launched a defence strategy in FY26, but revenue fell, cash burn increased and its statutory loss widened to $6.72 million. The auditor identified a material uncertainty over the company’s ability to continue as a going concern, despite a $5.2 million capital raising and planned debt conversions.

Kelsian Group has entered FY27 after a record financial year, the $149.9 million sale of its Tourism Portfolio and a sharp reduction in leverage. But the transport operator is also awaiting an independent review into a fatal June bus incident as it pursues fresh international growth.

Saunders International says it expects revenue growth and sustained second-half margin improvement in FY27 after reporting record FY26 revenue of A$305.6 million. Its opportunity pipeline reached A$5.1 billion, although converting that pipeline into profitable work remains the central test.

TALi Digital has appointed William Hamilton as chief executive and managing director, placing the former DigitalX executive at the centre of its Datasphere commercialisation push. The leadership change also moves Dr David Brookes to non-executive chair and includes a proposed performance-rights package subject to shareholder approval.

Lumos Diagnostics has expanded FebriDx deployment to 265 US healthcare sites across 29 states, while product revenue rose 224% in the first quarter. The commercial gains came alongside a US$4.7 million operating cash outflow, slower-than-planned paediatric study enrolment and a Hologic development timeline pushed to around June 2028.

NGX Limited (ASX:NGX) has secured rights to earn up to 85% in a large group of Namibian gold and copper exploration licences while raising A$3.6 million to fund the work. The transaction brings substantial exploration scale, but several licence transfers, renewals and environmental approvals remain outstanding.

Austral Gold lifted third-quarter production by 50% and moved into a US$2.5 million net cash position, but operational problems at Guanaco have forced a substantial reduction in full-year output guidance. Casposo is ramping up, although its cost outlook has also worsened.

Resonance Health has secured an oversubscribed $6.0 million placement to fund MRI endpoint expansion, new TrialsWest sites and development of its non-invasive liver fibrosis device. The raise lifts pro forma net cash to $7.9 million, but the most consequential project remains an investigational technology backed by a small preliminary dataset.

Kantra Copper has lifted Kanmantoo’s Ore Reserve by 31% to 5.2 million tonnes, adding a maiden reserve for Emily Star and extending the underground mine plan to December 2029. The expansion supports a positive pre-tax NPV, but the scheduled production rate remains below the company’s stated 2 million tonne annual goal.

Rimfire Pacific Mining’s latest Murga tests continue to show atmospheric scandium recovery, while a $2.3 million placement funds drilling and technical work across its NSW portfolio. The results remain early-stage, with projected long-term recoveries based on extrapolation rather than completed testing.

Chalice Mining is preparing to run an eight-week full-flowsheet pilot plant at Gonneville as it advances feasibility work, environmental approvals and formal copper and nickel offtake talks. The company ended September with A$53 million in cash and listed investments, but major project funding remains unresolved.

Cynata Therapeutics ended September with just A$175,000 in cash after a A$1.316 million quarterly operating drain, but says sweeping cuts and fresh funding could extend its runway into FY2028. The biotech has now reduced its workforce to zero, repaid its R&D loan and shifted focus to finding value for its Cymerus platform.

Boab Metals has strengthened the case for its Sorby Hills silver-lead project, extending the mine life to 10.5 years while reporting construction progress and higher Norton recoveries. The project remains targeted for first concentrate in Q3 2027, but the quarter also consumed A$30.9 million in cash and left the A$236 million debt facility undrawn.

FireFly Metals has struck a new copper-gold VMS system at Mount Joy, delivering a 22.5-metre intersection grading 2.5% copper equivalent near its Green Bay infrastructure in Newfoundland. A second hole encountered about 40 metres of semi-massive sulphides, although laboratory assays are still pending.

Brightstar Resources has secured A$82 million to accelerate exploration and early development work at Sandstone, where Two Mile Hill is emerging as a potential cornerstone asset. Genesis Minerals will invest A$30 million for a 5.4% stake, while Brightstar says Goldfields construction remains separately funded and on schedule for first gold in the June quarter of 2027.

Turaco Gold has reported extensions to high-grade mineralisation across its Afema project in Côte d’Ivoire, with a resource update due in the December quarter. The company finished September with $47.4 million in cash as it moves towards a Definitive Feasibility Study targeted for the June 2027 quarter.

IVE Group’s FY26 revenue slipped 1.8%, but stronger margins lifted underlying pre-AASB 16 NPAT by 3.0% to A$52.5 million and supported a higher final dividend. The marketing and communications group expects underlying pre-AASB 16 profit to be broadly stable in FY27 as new capacity and acquisitions begin to contribute.

Alara Resources delivered its strongest quarterly copper sales since commercial operations began, while production remained above nameplate capacity at its Oman mine. Yet the company says the parent may need to raise about A$6 million in FY27 to cover a projected cash shortfall.

Botanix’s Sofdra prescriptions rose 5.3% in the September quarter, but flat net revenue and a sharp cash decline have forced a major reset. The company is targeting a roughly 50% reduction in operating expenses while assessing licensing, acquisitions and broader strategic transactions.

Universal Store has opened FY27 with 9.3% growth in direct-to-customer sales, led by a sharp lift from Perfect Stranger. The retailer is maintaining its plan for 16 to 20 new stores despite continued weakness in CTC’s wholesale channel.

Viridis Mining and Minerals Limited (ASX:VMM) has moved its Colossus rare earths project into execution after reporting a US$1.20 billion after-tax NPV and securing strategic equity commitments of up to US$120 million. The project still needs definitive debt, offtake and approvals before a Final Investment Decision can unlock full construction.